March 19 (Bloomberg) — Most scientists who published articles supporting GlaxoSmithKline Plc ’s diabetes drug Avandia after it was linked to heart disease in 2007 had financial ties to the company, according to a Mayo Clinic report.
[tags]diabetic news, diabetes news[/tags]
No tags for this post.
